Therapeutic Devices · Watertown, MA · Founded 2021 · Privately Held (backing)
Developer of a targeted gene therapy intended to treat autoimmune diseases and cardiac diseases. Soufflé Therapeutics is based in Watertown, MA and was founded in 2021. It was valued at $345 million at its early-stage round in Oct 2025, the last priced event on record. It has raised $241 million across 1 recorded round; the latest was a $200 million Series A in Oct 2025.
PMV mark · valuation
$344.5M
Oct 2026
Priced at
its early-stage round
Oct 2025
Total raised
$240.6M
Last round
Early Stage VC (Series A)
Oct 2025
Cap table — not yet on record
Soufflé Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Soufflé Therapeutics with a free account
·The complete investor list: 13 names
·Watch Soufflé Therapeutics: the Monday email on marks, rounds and moves
Where does Soufflé Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Soufflé Therapeutics's 1 recorded funding rounds.
